Pfizer and Moderna adapt their vaccines under a new Covid-19 strain

The manufacturers of the most frequently used vaccines against COVID-19 in the United States reported that they have plans for the rapid adaptation of their vaccinations to the potential consequences associated with the new strain of coronavirus. This is reported by the New York Post edition.

The Pfizer vaccine manufacturer and Biontech said that if necessary, they calculate after 100 days to put a new vaccine adapted to a very infectious omicron strain of coronavirus.

Another vaccine manufacturer – MODERNA also stated that it works on a booster dose adapted to a new version of COVID-19. According to the representative of the company, Moderna has already begun to prepare a drug for testing.